InsidersTradesSigma
SK바이오사이언스 Stock: price and management transactions · South Korea · DART (FSS)
Follow the SK바이오사이언스 stock price and the full directors' dealings record of the company, a listed issuer based in South Korea. Shares are listed on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, SK바이오사이언스 has logged 2 reports. Market capitalisation: €3,075.5bn. The latest transaction was reported on 27 March 2026 (Purchase). Among the most active insiders: SK케미칼. All data is openly available.
2
Insider Decl.
0
Thresholds
€115,619
2 ops.
Buy Volume
·
0 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate SK바이오사이언스 Underperform (bearish), based on 4 analysts. Average price target: ₩32,750.
10Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 23,773 of 25,837 companies
19.9
score / 100
Value24
Quality16
FCF yld-5.3%
Earn yld-1.9%
EV/EBITDA·
ROE-4.3%
Gross mgn12%
Net mgn-8.8%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 27 March 2026